BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6606214)

  • 1. Circulating immune complexes in haemophilia and von Willebrand's disease.
    Passaleva A; Massai G; Morfini M; Longo G; Rossi Ferrini PL; Ricci M
    Scand J Haematol; 1983 Nov; 31(5):466-74. PubMed ID: 6606214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of circulating immune complexes on transfusional therapy in patients with hemophilia or von Willebrand's disease.
    Celada A; Aguado MT; Maire M; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Transfusion; 1984; 24(1):46-52. PubMed ID: 6420954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in hemophilia.
    Poskitt TR; Poskitt PK; Bean CA; Arkel YS
    Am J Hematol; 1981 Sep; 11(2):147-52. PubMed ID: 6795922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders.
    Anh-Tuan N; Novák E; Hollán SR
    Vox Sang; 1981 Jan; 40(1):12-6. PubMed ID: 6971526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease.
    Hilgartner MW; Giardina P
    Transfusion; 1977; 17(5):495-9. PubMed ID: 302996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and clinical and transfusional significance of rheumatoid factor in patients with haemophilia and von Willebrand's disease.
    Celada A; Aguado MT; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Vox Sang; 1984; 47(4):271-5. PubMed ID: 6333107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A.
    Holmberg L; Mannucci PM; Turesson I; Ruggeri ZM; Nilsson IM
    Scand J Haematol; 1974; 13(1):33-8. PubMed ID: 4606548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].
    Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y
    Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders.
    Ng HW
    Ann Acad Med Singap; 1984 Jul; 13(3):524-6. PubMed ID: 6335008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.
    Larsson SA
    Acta Med Scand Suppl; 1984; 684():1-72. PubMed ID: 6611018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.
    Kazatchkine MD; Sultan Y; Burton-Kee EJ; Mowbray JF
    Clin Exp Immunol; 1980 Feb; 39(2):315-20. PubMed ID: 6771074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cell mediated and humoral immunity in haemophilia and related disorders.
    Moffat EH; Bloom AL; Jones J; Matthews N; Newcombe RG
    Br J Haematol; 1985 Sep; 61(1):157-67. PubMed ID: 3931666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
    Schulman S; Wiechel B
    Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serum.
    Peake IR; Bloom AL; Giddings JC; Ludlam CA
    Br J Haematol; 1979 Jun; 42(2):269-81. PubMed ID: 313808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.
    Enck RE; Betts RF; Brown MR; Miller G
    Transfusion; 1979; 19(1):32-8. PubMed ID: 219564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.